Press Releases

PANTHERx® Specialty Pharmacy, The Rare Disease Specialty Pharmacy , and RxCrossroads  by McKesson, the leading commercial solutions partner for life sciences companies, announced their collaborative program to simplify the channel for precision medicine therapies. Recognizing a...

Regeneron Pharmaceuticals, Inc. and Sanofi announced that new analyses on mortality from the 18,924-patient ODYSSEY OUTCOMES trial were presented at the American Heart Association (AHA) Scientific Sessions 2018. Praluent® (alirocumab) Injection was associated with fewer deaths...

Quanticate, a data-focused clinical research organisation (CRO), has announced that it is partnering with Lancaster University to sponsor a STOR-i PhD project. The partnership will see Quanticate support research into optimizing clinical trial design for rare...

Zenith Technologies, a world leader in delivering GMP manufacturing software solutions to the life sciences industry, has launched a new virtual customised training service to tackle critical gaps in industry manufacturing software and process training. The...

Lonza announced that the recombinant Factor C Assay has been used for endotoxin testing of Eli Lilly’s Emgality™ , the first drug approved by the U.S. FDA to have been released using this method instead of traditional Limulus Amebocyte...

bioLIVE – the bioprocessing and manufacturing event running adjacent to CPhI Worldwide – will next year incorporate BioProduction Congress to become bioLIVE at CPhI Worldwide. The exhibition will continue under the bioLIVE brand, with BioProduction Congress...

The Lubrizol Corporation announces a proprietary nasal delivery formulation of diazepam for the treatment of epilepsy which was developed by contract development and manufacturing organization (CDMO), Particle Sciences, a Lubrizol LifeSciences company, has been submitted as a NDA to...